FDA delays decision on Moderna vaccine for teens under 17: The company announced Sunday that the agency said it needs more time to examine data on a rare cardiac side effect seen in young males after Moderna’s second shot, with any approval likely pushed back to January 2022. Read moreContinue Reading

MONDAY, Nov. 1, 2021 (HealthDay News) — An experimental Breathalyzer-type test can detect COVID-19 within seconds and could become a noninvasive, faster alternative to nasal swab tests, researchers report. COVID-19 infection produces a distinct breath print from the interaction of oxygen, nitric oxide and ammonia in the body, the investigatorsContinue Reading